CClinicalTrials.gg
CompletedNCT03686553Updated Sep 28, 2018

St. Barbara Specialised Regional Hospital No. 5: Surveillance of Healthcare-Associated Infections

An observational study in Surgical Site Infections, sponsored by Polskie Towarzystwo Zakażeń Szpitalnych. Completed. Per ClinicalTrials.gov, last updated 2018-09-28.

Sponsored by Polskie Towarzystwo Zakażeń Szpitalnych · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
5,239
Sex
All
01

Study summary

Retrospective laboratory-based data collection study of surgical site infections: Surveillance of Healthcare-Associated Infections in Orthopaedic and Trauma Surgery Unit in Sosnowiec, Poland;

02

Conditions studied

03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's enrollment of 5,239 is above the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Polskie Towarzystwo Zakażeń Szpitalnych is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

patients undergoing surgery in the Orthopaedic and Trauma Surgery Unit in Sosnowiec, Poland

Inclusion criteria

  • patient being treated in the Department and Clinic of Orthopaedic and Trauma Surgery, St. Barbara Specialised Regional Hospital No. 5, Sosnowiec
  • patients undergoing surgery in studied unit

Exclusion criteria

Exclusion Criteria:

  • under 18 years of age
  • surgery of a different type than orthopedics
  • non-surgical treatment
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
5,239 participants (actual)
Patient registry
No

Groups and cohorts

  • infected, with SSI

    patients with SSI

    Other: laboratory-based data collection

  • non-infected

    patients without SSI

    Other: laboratory-based data collection

Interventions

  • Otherlaboratory-based data collection

    laboratory-based surveillance of SSI

06

What researchers measure

Primary outcomes

  1. surgical site infection incidence rate

    the cumulative incidence of surgical site infection (SSI) was calculated by dividing the number of SSI cases by the number of patients undergoing surgery and multiplying by 100

    Time frame: The follow-up period was 30 days for the superficial SSI's, and 90 days for deep or organ/space infections following arthroplasties

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03686553
Lead sponsor
Polskie Towarzystwo Zakażeń Szpitalnych
Responsible party
Sponsor
First posted
Sep 27, 2018
Start date
Jan 2013
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Sep 28, 2018

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion